Dietary-feeding of grape seed extract prevents azoxymethane-induced colonic aberrant crypt foci formation in fischer 344 rats

Molecular Carcinogenesis

Volumn 49, Issue 7, 2010, Pages 641-652

  Velmurugan, Balaiya ^a   Singh, Rana P ^a,b   Agarwal, Rajesh ^a,c   Agarwal, Chapla ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

^c UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Aberrant crypt foci; Chemoprevention; Colorectal cancer; Grape seed extract

Indexed keywords

AZOXYMETHANE; BETA CATENIN; CYCLIN D1; CYCLOOXYGENASE 2; GRAPE SEED EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; FEEDING; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; AZOXYMETHANE; BETA CATENIN; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; CYCLIN D1; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GRAPE SEED EXTRACT; MICROTUBULE-ASSOCIATED PROTEINS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED F344;

ANIMALIA; RATTUS; VITACEAE;

EID: 77954465641     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20643     Document Type: Article

References (50)

1. Huerta S. Recent advances in the molecular diagnosis and prognosis of colorectal cancer. Expert Rev Mol Diagn 2008;8:277-288.
2. American Cancer Society. Colorectal cancer facts and figures. Atlanta, GA: American Cancer Society; 2009.
3. Half E, Arber N. Colon cancer: Preventive agents and the present status of chemoprevention. Expert Opin Pharmacother 2009;10:211-219.
4. Veeriah S, Miene C, Habermann N, et al. Apple polyphenols modulate expression of selected genes related to toxicological defense and stress response in humancolon adenoma cells. Int J Cancer 2008;122:2647-2655.
5. Rudolf E, AndelováH, Cervinka M. Polyphenolic compounds in chemoprevention of colon cancer - Targets and signaling pathways. Anticancer Agents Med Chem 2007;7:559-575.
6. Bagchi D, Bagchi M, Stohs S, et al. Cellular protection with proanthocyanidins derived from grape seeds. Ann N Y Acad Sci 2002;957:260-270.
7. Wen W, Lu J, Zhang K, Chen S. Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev Res (Phila, PA) 2008;1:554-561.
8. Singletary KW, Meline B. Effect of grape seed proanthocyanidins on colon aberrant crypts and breast tumors in a rat dual-organ tumor model. Nutr Cancer 2001;39:252-258. (Pubitemid 33694044)
9. Zhao J, Wang J, Chen Y, Agarwal R. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 1999;20:1737-1745.
10. Agarwal C, Sharma Y, Agarwal R. Anticarcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU145 cells: Modulation of mitogenic signaling and cell-cycle regulators and induction of G1 arrest and apoptosis. Mol Carcinog 2000;28:129-138.
11. Singh RP, Tyagi AK, Dhanalakshmi S, Agarwal R, Agarwal C. Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3. Int J Cancer 2004;108:733-740.
12. Kaur M, Singh RP, Gu M, Agarwal R, Agarwal C. Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells. Clin Cancer Res 2006;12:6194-6202.
13. Kaur M, Agarwal C, Agarwal R. Anti-cancer and cancer chemopreventive potential of grape seed extract and other grape-based products. J Nutr 2009;139:1806S-1812S.
14. Raina K, Singh RP, Agarwal R, Agarwal C. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice. Cancer Res 2007;67:5976-5982.
15. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 1987;37:147-151.
16. Guruswamy S, Swamy MV, Choi CI, Steele VE, Rao CV. S-adenosyl L-methionine inhibits azoxymethane-induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco-2 cell growth in 3D culture. Int J Cancer 2008;122:25-30.
17. Velmurugan B, Singh RP, Tyagi A, Agarwal R. Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats. Cancer Prev Res (Phila, PA) 2008;1:376-384.
18. Paul S, Dey A. Wnt signaling and cancer development: Therapeutic implication. Neoplasma 2008;55:165-176.
19. Kim HS, Kundu JK, Lee JS, Oh TY, Na HK, Surh YJ. Chemopreventive effects of the standardized extract (DA-9601) of Artemisia asiatica on azoxymethane-initiated and dextran sulfate sodium-promoted mouse colon carcinogenesis. Nutr Cancer 2008;60:90-97.
20. Yamakoshi J, Saito M, Kataoka S, Kikuchi M. Safety evaluation of proanthocyanidin-rich extract from grape seeds. Food Chem Toxicol 2002;40:599-607.
21. Naryzhny SN. Proliferating cell nuclear antigen:Aproteomics view. Cell Mol Life Sci 2008;65:3789-3808.
22. Baldwin AS, Jr. The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 1996;14:649-683.
23. Bonovas S, Tsantes A, Drosos T, Sitaras NM. Cancer chemoprevention: A summary of the current evidence. Anticancer Res 2008;28:1857-1866. (Pubitemid 351892897)
24. Marshall JR. Prevention of colorectal cancer: Diet, chemoprevention, and lifestyle. Gastroenterol Clin North Am 2008;37:73-82.
25. Mason JB. Nutritional chemoprevention of colon cancer. Semin Gastrointest Dis 2002;13:143-153.
26. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004;95:475-480.
27. Janakiram NB, Steele VE, Rao CV. Estrogen receptor-beta as a potential target for colon cancer prevention: Chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats. Cancer Prev Res (Phila, PA) 2009;2:52-59.
28. Alrawi SJ, Schiff M, Carroll RE, et al. Aberrant crypt foci. Anticancer Res 2006;26:107-119.
29. Feregrino-Pérez AA, Berumen LC, García-Alcocer G, et al. Composition and chemopreventive effect of polysaccharides from common beans (Phaseolus vulgaris L.) on azoxymethane-induced colon cancer. J Agric Food Chem 2008;56:8737-8744.
30. Yasui Y, Miyamoto S, Kim M, Kohno H, Sugie S, Tanaka T. Aqueous and ethanolic extract fractions from the Brazilian propolis suppress azoxymethane-induced aberrant crypt foci in rats. Oncol Rep 2008;20:493-499.
31. Kohno H, Tanaka T, Kawabata K, et al. Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int J Cancer 2002;101:461-468.
32. Trosko JE, Ruch RJ. Cell-cell communication in carcinogenesis. Front Biosci 1998;3:208-236.
33. Arakaki J, Suzui M, Morioka T, et al. Antioxidative and modifying effects of a tropical plant Azadirachta indica (Neem) on azoxymethane-induced preneoplastic lesions in the rat colon. Asian Pac J Cancer Prev 2006;7:467-471.
34. Morioka T, Suzui M, Nabandith V, et al. Modifying effects of Terminalia catappa on azoxymethane-induced colon carcinogenesis in male F344 rats. Eur J Cancer Prev 2005;14:101-105.
35. Wang HL, Wang J, Xiao SY, et al. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas over expressing beta-catenin. Int J Cancer 2002;101:301-310.
36. Bondi J, Bukholm G, Nesland JM, Bukholm IR. Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas. APMIS 2004;112:49-56.
37. Issa AY, Volate SR, Muga SJ, Nitcheva D, Smith T, Wargovich MJ. Green tea selectively targets initial stages of intestinal carcinogenesis in the AOM-ApcMin mouse model. Carcinogenesis 2007;28:1978-1984.
38. Sharma G, Tyagi AK, Singh RP, Chan DC, Agarwal R. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells. Breast Cancer Res Treat 2004;85:1-12.
39. Andersen MH, Svane IM, Becker JC, Straten PT. The universal character of the tumor-associated antigen survivin. Clin Cancer Res 2007;13:5991-5994.
40. Watanabe K, Kawamori T, Nakatsugi S, Wakabayashi K. COX-2 and iNOS, good targets for chemoprevention of colon cancer. Biofactors 2000;12:129-133. (Pubitemid 32107396)
41. van der Woude CJ, Kleibeuker JH, Jansen PL, Moshage H. Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract. Apoptosis 2004;9:123-130.
42. Janakiram NB, Indranie C, Malisetty SV, Jagan P, Steele VE, Rao CV. Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells. Pharm Res 2008;25:2151-2157.
43. Vanamala J, Leonardi T, Patil BS, et al. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis 2006;27:1257-1265.
44. Luceri C, Caderni G, Sanna A, Dolara P. Red wine and black tea polyphenols modulate the expression of cycloxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced f344 rat colon tumors. J Nutr 2002;132:1376-1379. (Pubitemid 34606479)
45. Reddy BS, Hirose Y, Lubet R, et al. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 2000;60:293-297.
46. Yoshimi N, Shimizu M, Matsunaga K, et al. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane. Jpn J Cancer Res 1999;90:406-412.
47. Murakami A. Chemoprevention with phytochemicals targeting inducible nitric oxide synthase. Forum Nutr 2009;61:193-203.
48. Olivier S, Robe P, Bours V. Can NF-κB be a target for novel and efficient anti-cancer agents? Biochem Pharmacol 2006;72:1054-1068.
49. Lind DS. NF-κB is upregulated in colorectal cancer. Surgery 2001;130:363-369.
50. Surh YJ, Chun KS, Cha HH, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Downregulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 2001;480:243-268.